Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tomasz Dembowski
Observed name:
T Dembowski
Institutions:
Medical University of Lodz,
Szpital Zakonu Bonifratrów św. Jana Grandego w Krakowie
Observed institutions:
Medical University of Lodz,
Szpital Zakonu Bonifratrów św. Jana Grandego w Krakowie
ORCID:
0000-0002-3323-4036
Observed ORCID:
0000-0002-3323-4036
OpenAlex ID:
A5046822519
Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of multicenter registry (CANT II Study)
2022
·
Maciej T. Wybraniec
, Aleksander Maciąg
, et al.
·
Polskie Archiwum Medycyny Wewnętrznej
·
19
PDF
Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and sex differences: Insights from the CANT II Study
2023
·
Maciej T Wybraniec
, Aleksander Maciąg
, et al.
·
Kardiologia Polska
·
8
PDF
Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study
2022
·
Beata Ceynowa-Sielawko
, Maciej T. Wybraniec
, et al.
·
International Journal of Environmental Research and Public Health
·
6
PDF
Probiotics and gut-skin axis - new look on factors affecting skin condition
2023
·
Aleksandra Małolepsza
, Tomasz Dembowski
·
Journal of Education Health and Sport
·
1
PDF
The reinvented old player – an antazoline is effective in pharmacological cardioversion of atrial fibrillation
2021
·
D Miskowiec
, T Dembowski
, et al.
·
European Heart Journal
Cinderella drug: an antazoline is effective in pharmacological cardioversion of atrial fibrillation - Single center experience
2021
·
D Miskowiec
, T Dembowski
, et al.
·
EP Europace
PDF
Show more works
View as search
Works count:
6
Citation count:
34
H-index:
3
I10-index:
1
Year
Topic
Type